HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pankaj Bhargava Selected Research

tirabrutinib

6/2022Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
4/2022Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
1/2021Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
1/2020Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pankaj Bhargava Research Topics

Disease

14Neoplasms (Cancer)
12/2021 - 09/2003
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2022 - 01/2020
4Hepatocellular Carcinoma (Hepatoma)
03/2013 - 04/2006
4Hypertension (High Blood Pressure)
11/2011 - 04/2006
4Neutropenia
01/2010 - 04/2006
3Neoplasm Metastasis (Metastasis)
01/2021 - 07/2005
3Adenocarcinoma
01/2021 - 02/2008
3Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 01/2004
3Fatigue
11/2011 - 04/2006
3Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2010 - 09/2003
2Hemorrhage
01/2021 - 08/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 12/2020
2Carcinoma (Carcinomatosis)
11/2020 - 01/2005
2Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2012 - 10/2010
2Thrombocytopenia (Thrombopenia)
08/2012 - 06/2009
2Renal Cell Carcinoma (Grawitz Tumor)
05/2012 - 04/2011
2Leukopenia
06/2009 - 04/2006
2Hypersensitivity (Allergy)
01/2004 - 01/2004
1Fibrosis (Cirrhosis)
12/2021
1Stomach Neoplasms (Stomach Cancer)
12/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Disease Progression
01/2021
1Diarrhea
12/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2020
1Carcinoid Tumor (Carcinoid)
08/2012
1Lymphopenia (Lymphocytopenia)
08/2012
1Small Cell Carcinoma
10/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2010
1Leukemia
08/2010
1Peripheral Nervous System Diseases (PNS Diseases)
01/2010
1Gallbladder Neoplasms (Gallbladder Cancer)
02/2008
1Liver Neoplasms (Liver Cancer)
08/2007
1Fever (Fevers)
08/2007
1Hot Flashes
12/2003
1Breast Neoplasms (Breast Cancer)
12/2003

Drug/Important Bio-Agent (IBA)

6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 01/2004
6GemcitabineFDA Link
11/2020 - 09/2003
5idelalisibIBA
06/2022 - 01/2020
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 07/2009
4tirabrutinibIBA
06/2022 - 01/2020
4Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2009
4Transaminases (Aminotransferases)IBA
12/2020 - 04/2006
4Bevacizumab (Avastin)FDA Link
08/2012 - 04/2006
36- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA
04/2022 - 01/2020
3andecaliximabIBA
12/2021 - 11/2020
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2021 - 11/2020
3Monoclonal AntibodiesIBA
01/2021 - 08/2012
3tivozanibIBA
01/2013 - 11/2011
2obinutuzumabIBA
06/2022 - 04/2022
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2007
2Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 10/2010
2Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 09/2003
2Tyrosine Kinase InhibitorsIBA
03/2013 - 08/2012
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2012 - 04/2011
2Phosphotransferases (Kinase)IBA
11/2011 - 07/2009
1Extracellular Matrix ProteinsIBA
12/2021
1NivolumabIBA
12/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021
1ibrutinibIBA
01/2021
1EnzymesIBA
01/2021
1Leucovorin (Folinic Acid)FDA Link
01/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2020
1130-nm albumin-bound paclitaxelIBA
11/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2020
1afliberceptIBA
01/2015
1cediranib (AZD2171)IBA
03/2013
1EverolimusFDA Link
01/2013
1Temozolomide (Temodar)FDA LinkGeneric
08/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
05/2012
1Biological ProductsIBA
11/2011
1Tyrosine (L-Tyrosine)FDA Link
11/2011
1Proteins (Proteins, Gene)FDA Link
04/2011
1Pemetrexed (MTA)FDA Link
10/2010
1Cytotoxins (Cytolysins)IBA
10/2010
1Folic Acid AntagonistsIBA
10/2010
1Alanine Transaminase (SGPT)IBA
01/2010
1Sunitinib (Sutent)FDA Link
06/2009
1Cisplatin (Platino)FDA LinkGeneric
02/2008
1Cetuximab (Erbitux)FDA Link
08/2007
1LigandsIBA
08/2007
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2007
1lestaurtinibIBA
01/2005
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2005
1PlatinumIBA
01/2004
1TamoxifenFDA LinkGeneric
12/2003
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2003
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
12/2003
1Paroxetine (Paxil)FDA LinkGeneric
12/2003

Therapy/Procedure

6Therapeutics
01/2021 - 01/2004
3Drug Therapy (Chemotherapy)
11/2020 - 09/2003
1Surgical Instruments (Clip)
08/2007
1Radiofrequency Ablation
07/2005